Glycopeptide Biomarkers in Serum Haptoglobin for Hepatocellular Carcinoma Detection in Patients with Nonalcoholic SteatohepatitisJianhui Zhu, David M. Lubman, Junfeng Huang et al.|Journal of Proteome Research|2020Cited by 53
Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry MethodYu Lin, David M. Lubman, Jianhui Zhu et al.|ACS Omega|2022Cited by 17
Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approachYehia Mechref, David M. Lubman, Wenjing Peng et al.|Advances in cancer research|2022Cited by 8
Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid CancerMaria E. Cabanillas, Suyu Liu, Bryan Fellman et al.|Thyroid|2025Cited by 8
Cobimetinib plus atezolizumab for <i>RAS</i> and <i>NF</i>1/2-mutated poorly differentiated thyroid carcinoma.Sarah Hamidi, Ramona Dadu, Naifa L. Busaidy et al.|Journal of Clinical Oncology|2024Cited by 4